BsUFA IV: Fiscal Years 2028-2032
The FDA announced the kickoff of the fourth Biosimilar User Fee Act (BsUFA IV) reauthorization, covering fiscal years 2028‑2032. A public meeting was held on December 3, 2025 to launch the process, following the 2022 law that reauthorized BsUFA II. BsUFA III expires in September 2027, so new legislation will be required to continue funding biosimilar reviews. The agency will seek input from drug makers, patient groups, and other stakeholders as it drafts enhancements.
In a First, Scientists Are Rewinding Human Cells Back to a ‘Youthful’ State. Is This the Dawn of Immortality?
Scientists are advancing partial cellular reprogramming to reverse age‑related decline while preserving cell identity. YouthBio Therapeutics is preparing a first‑in‑human trial of its brain‑targeted YB002 program for Alzheimer’s after receiving FDA feedback. Parallel efforts such as Life Biosciences’ ER‑100 aim...
Study Finds Patients Willing to Use Lower-Cost Treatments to Keep Weight Off, Allowing More Access to GLP-1s
A University of Michigan College of Pharmacy study of more than 700 U.S. adults with obesity found that over 80% support insurer strategies that cover full‑dose GLP‑1 injections during the active weight‑loss phase and then transition patients to lower‑cost maintenance...
WEDI Launches Interoperability Testing Directory
WEDI has launched a free, web‑based directory that matches payers, providers, and vendors seeking partners to test the CMS‑0057‑F APIs required for the January 1 2027 interoperability deadline. The service collects basic information—organization name, API versions, testing windows—and makes it publicly searchable,...
Talkspace Expands U.S. Navy Mental Health Partnership to 13 Bases
Talkspace is extending its mental‑health partnership with the U.S. Navy to 13 installations, adding the Talkspace Go self‑paced app to the benefits of more than 40,000 sailors and their families. The service provides virtual therapy for a wide range of...
A Candid Look at Antifungal Treatment Durations
Current IDSA guidelines mandate at least 14 days of antifungal therapy after blood‑culture clearance for invasive candidiasis, a rule rooted in a three‑decade‑old trial. Recent pilot and retrospective studies suggest that a 5‑10‑day course can achieve comparable cure rates and...
Policy Sclerosis Is Ravaging the NHS and Whitehall
The Health Foundation reports that UK healthy life expectancy (HLE) has slipped to just under 61 years, dropping the country to 20th place among 21 high‑income nations. The decline follows a decade‑long fall in HLE, contrasting with gains elsewhere. The...
FDA Approves Fruit-Flavored Vapes As Controversy Mounts For Makary
The FDA authorized marketing of fruit‑flavored e‑cigarette products on May 5, marking the first such approval in U.S. history. The move follows reports that President Donald Trump pressured FDA Commissioner Marty Makary to green‑light the flavors, a promise he made during...
Resilia Tissue Developed by Edwards Lifesciences Associated with Long-Term Durability
Edwards Lifesciences presented 10‑year results from the COMMENCE surgical aortic valve trial, showing its Resilia tissue leaflets achieve 97.9 % freedom from structural valve deterioration. The technology combines calcium‑blocking chemistry with dry storage to limit calcification, delivering stable hemodynamics and low...
Asthma-Related ER Visits Spike in Baltimore After Nighttime Heatwaves
Johns Hopkins researchers found a clear surge in asthma‑related emergency‑room visits in Baltimore weeks after nighttime heat waves hit neighboring communities. The study, published in GeoHealth, shows that the city’s Code Red Extreme Heat alert, which only tracks daytime temperatures, overlooks...
Stakeholders Await Impact Of Swift Provider Revalidation
The Centers for Medicare & Medicaid Services (CMS) has announced a swift provider revalidation mandate targeting home and community‑based service providers. Stakeholders, including provider groups and patient advocates, say it is too early to assess the policy’s impact on workforce...
FDA Vaccine Studies Censored by Trump Admin After Finding Benefits of Shots
The Food and Drug Administration, under the Department of Health and Human Services, blocked the publication of two internal studies that demonstrated the safety and efficacy of COVID‑19 vaccines, and prevented two Shingrix (shingles vaccine) abstracts from being presented at...
The Future of Healthcare Is About Giving Back Attention
Healthcare providers are facing an "attention crisis" as clinicians juggle patients, screens, and endless alerts. While AI promises speed and scale, the real need is for tools that reclaim clinicians' time rather than add features. athenaInstitute’s study shows 63% of...
Tofersen, a New Treatment for A.L.S., Reverses Symptoms for Some
Tofersen, the first FDA‑approved therapy targeting the SOD1 genetic form of ALS, is showing functional gains in a subset of patients. In a case highlighted by the New York Times, 58‑year‑old Amanda Sifford’s lung capacity rebounded from 48% to 86%...
LTZ Therapeutics Secures $38M to Advance Myeloid Engager Immunotherapy Pipeline
LTZ Therapeutics announced an oversubscribed $38 million financing round led by GL Ventures, bringing its total capital to roughly $130 million since 2022. The funds will propel the Universal Myeloid Cell Engager (U‑MCE) platform, supporting the Phase 1 trial of lead bispecific antibody...
COVID-19 Prevention Gaps in Immunocompromised Patients: Muhammed Bilal Abid, MD
Dr. Muhammed Bilal Abid highlighted persistent COVID‑19 prevention gaps for immunocompromised patients, especially those with chronic lymphocytic leukemia (CLL). He cited the CANOPY trial, which reported zero symptomatic COVID‑19 cases over six months in a small CLL cohort receiving the monoclonal antibody...
Cannabis Execs Anticipate Tax Benefits From Rescheduling
The DOJ and DEA reclassified medical cannabis as a Schedule III drug on April 23, ending its Schedule I status. This change eliminates the IRS 280E restriction for medical cannabis businesses, potentially cutting tax burdens by up to half. Industry leaders Curaleaf and Green...
Conversational AI Shows Promise in Easing Symptoms of Anxiety and Depression
A randomized trial of 995 Israeli university students found that a conversational AI mental‑health app, Kai, produced greater reductions in anxiety and depression than traditional face‑to‑face group therapy and a wait‑list control over a 12‑week period. The AI group also...
Moss Powering the Next Drug Frontier
Eleva is commercializing a moss‑based biomanufacturing platform that can produce complex glycoproteins difficult to express in traditional CHO or yeast systems. The German firm has advanced its first candidate, a recombinant alpha‑galactosidase for Fabry disease, into clinical trials and is...
First U.S. Patients Treated With Microrobotic Surgery For Alzheimer’s
A microrobotic surgery trial for Alzheimer’s disease began at Baptist Health in Jacksonville, treating the first patient with moderate disease. Medical Microinstruments Inc. (MMI) plans to enroll 15 participants and monitor them for a year, aiming to clear cervical lymph‑node...
Financings for May 6, 2026
UK‑based Cytospire Therapeutics announced a £61 million (≈$82.7 million) Series A round to accelerate its EGFR‑targeted T‑cell engager pipeline for solid tumours. The capital backs multiple pre‑clinical programs and reflects strong investor confidence in next‑generation immunotherapies. Bio Korea 2026 highlighted a shift in...
Examining the Distinct Effects of Structural, Financial, and Information-Sharing Integration on Hospital Costs
A recent panel study of 427 California hospitals (2014‑2016) examined three integration dimensions—structural, financial and information‑sharing—and their impact on hospital spending. Using hospital fixed‑effects regressions, the authors found that higher financial integration, measured by the share of revenue under shared‑risk...
Other News to Note for May 6, 2026
Cytospire Therapeutics announced a £61 million (≈$82.7 million) Series A round to advance its next‑generation T‑cell engager platform targeting the epidermal growth factor receptor (EGFR) in solid tumours. The funding will accelerate pre‑clinical and early‑clinical programs aimed at delivering more selective immunotherapies. Meanwhile,...
IPLEDGE Hurdles Block some Inmates From Receiving Isotretinoin in Jails, Prisons
The FDA‑run iPLEDGE REMS program blocks many incarcerated patients from receiving isotretinoin because it requires pharmacies to register with an NCPDP number—a identifier jails and prisons do not possess. In addition, the system mandates a phone number or email for...
CCTA Brings Clarity, Better Outcomes to CTO PCI
A systematic review of 56 studies shows that coronary CT angiography (CCTA) performed before chronic total occlusion (CTO) percutaneous coronary intervention (PCI) enhances procedural planning and improves patient outcomes. The authors identified three concrete benefits: better case selection, more precise...
WTWH Healthcare Announces the Future Leaders Class of 2026
WTWH Healthcare, a division of WTWH Media, announced its 2026 Future Leaders Class, recognizing professionals under 40 who are shaping aging and healthcare. The honorees span providers and vendors across sectors such as home health, behavioral health, hospice, senior living,...
Insulet Raises Revenue Expectations for 2026
Insulet Corp. raised its 2026 revenue growth outlook to 21%‑23% on a constant‑currency basis, up from the prior 20%‑22% range. The company posted Q1 revenue of $761.7 million, a 34% year‑over‑year increase, and net income of $91.1 million. Growth is being driven...
How Early Action May Reduce Fracture-Related Infections
Fracture‑related infection (FRI) affects 1% of closed fractures and up to 30% of severe open injuries, posing a costly challenge for orthopedic trauma care. Early suspicion—based on wound drainage, redness, or implant instability—enables prompt diagnosis, which markedly lowers the risk...
Fathom Secures Strategic Investment From CVS Health Ventures to Scale Autonomous Medical Coding
Fathom, a leader in autonomous medical coding, secured a strategic investment from CVS Health Ventures to accelerate its platform that automates over 90% of coding tasks across multiple specialties. The company, recently named the #1 solution for Reducing the Cost...
Carlyle Acquires Knack RCM and EqualizeRCM to Build Global AI-Native Healthcare RCM Platform
Carlyle has taken a majority stake in Knack RCM and EqualizeRCM, merging them into a single AI‑native revenue cycle management platform. The combined entity leverages Equalize’s Bill Smart denial‑prediction AI and Knack’s global delivery footprint of 8,000 staff and its...
A New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells' DNA
Researchers have engineered a novel CRISPR protein, Cas12a2, that acts as a molecular shredder, destroying DNA in cells that express a specific RNA trigger. In vitro, Cas12a2 cut the growth of KRAS‑mutant lung‑cancer cells by 50% and eliminated over 90%...
J&J’s Ottava Robot Meets Goals in Gastric Bypass Study
Johnson & Johnson reported that its investigational Ottava robotic system met safety and efficacy endpoints in a 30‑patient gastric bypass study, achieving an average 30‑pound weight loss within 30 days and no device‑related adverse events. All procedures were completed robotically...
IV Ketamine Shows Rapid Benefits for Suicide Risk, Depression in Major Depressive Episodes
A new meta‑analysis of 26 randomized trials involving 1,166 patients shows that intravenous ketamine rapidly alleviates both suicidal ideation and depressive symptoms in major depressive episodes. Single infusions cut suicidal scores by an SMD of –0.69 within 24 hours and depressive...
A Low-Cost Rotavirus Test Could Save Childrens’ Lives in Nigeria
Researchers at Obafemi Awolowo University have created a low‑cost, point‑of‑care rotavirus test that works without electricity or specialized training. The nanobead‑based kit showed 88% sensitivity in pilot hospitals, beating the standard ELISA test’s 60% sensitivity. Rotavirus accounts for nearly half...
Lilly Inflates US Facility Investment Spending by $4.5bn
Eli Lilly has increased its U.S. capital‑investment program by $4.5 billion, bringing total spending in Indiana to $21 billion since 2020. The new funding supports the Lebanon Advanced Therapies plant, the company’s first dedicated genetic‑medicine manufacturing site, and future API and Foundry facilities....
Researchers Receive Grants From ASRT Foundation
The ASRT Foundation awarded two Emerging Researchers Grants of $4,000 each to support innovative projects in radiologic science. Dr. Chad Dall of Bellin College will pilot a graphic‑novel‑based curriculum to improve student understanding of X‑ray production. Dr. Kerry Dunn, with...
The Trump Administration Is Bringing Back Flavored Vapes. Advocates and Lawmakers Say the Risks Outweigh the Benefits
The FDA has granted approval for four fruit‑ and mint‑flavored vaping products from Glas, marking a reversal of the Biden administration’s flavor bans. Glas secured the authorization by demonstrating an age‑verification system that uses government IDs, Bluetooth pairing, and random...
First Rehabilitation Boosts Revenue 37% with Outpatient Platform
First Rehabilitation, a three‑location outpatient physical therapy provider in Palm Beach County, replaced its fragmented, paper‑heavy operations with Spry's integrated platform. The new system combined scheduling, documentation, billing, eligibility checks and reporting, and introduced an AI‑driven Scribe for real‑time note...
Setting the Record Straight: Three Ways the Hospital‑blame Narrative Gets It Wrong
A recent New York Times guest essay blames hospitals for the 320 percent rise in insurance premiums over the past 25 years, but the argument overlooks how hospitals are largely price takers under Medicare, Medicaid and negotiated commercial contracts. The piece also excuses commercial...
The Risk of Keeping Humans in Healthcare AI's Loop
Regulators are mandating that clinicians review AI‑generated recommendations before any patient‑care decision is made. Blue x Blue founder Julia Zarb cautions that this pre‑emptive oversight could expose doctors and health systems to heightened liability. The shift moves the safety net from post‑decision...
Breaches in Cybersecurity Could Disrupt, Affect Patient Care: Tarun Sondhi
Accenture’s cybersecurity lead Tarun Sondhi warned that the growing reliance on electronic devices and interconnected vendor platforms is expanding the attack surface in health care. Breaches can cripple systems, delay access to patient records, and disrupt scheduling, directly affecting treatment...
ANA Releases Landmark Consensus Report on Artificial Intelligence in Nursing Practice
The American Nurses Association unveiled a landmark consensus report that sets guardrails for artificial intelligence in nursing practice. The document highlights automation bias and erosion of professional judgment as primary safety risks, insisting that AI must support—not replace—nurse decision‑making. It...
Physicians Chime In: Coronary Plaque Staging Offers More Precise Cardiac Patient Management
Heartflow’s Plaque Staging introduces a plaque‑volume based risk model that outperforms traditional stenosis and clinical scores. The framework is backed by data from more than 23,000 patients with up to 16 years of follow‑up, showing total plaque volume (TPV) predicts events...
SCCT President: Key Trends in Cardiac CT
SCCT President Chinnaiyan outlined how cardiac CT is evolving from a diagnostic tool to an AI‑driven platform for structural heart planning, PCI guidance, and preventive cardiology. New reimbursement codes for AI plaque assessment and FFR‑CT are accelerating adoption, while CCTA‑based...
The VESALIUS-CV Trial
In the VESALIUS-CV trial, researchers evaluated the impact of adding the PCSK9 inhibitor evolocumab to standard lipid‑lowering therapy in patients at high cardiovascular risk who had never experienced a myocardial infarction or stroke. Over a median follow‑up of 3.2 years,...
Cyclin E1 and CCNE1 Shift in Ovarian Cancer Post-PARP
The British Journal of Cancer study shows high‑grade serous ovarian carcinoma tumors develop resistance to PARP inhibitors by up‑regulating Cyclin E1 and amplifying the CCNE1 gene. Researchers compared pre‑ and post‑treatment samples using FISH and IHC, finding a significant rise in...
Why the Pharma Industry Must Rethink Copay Solutions to Put Patients First
Affordability remains the biggest hurdle for U.S. patients seeking prescription therapies, as high‑deductible health plans and rising out‑of‑pocket costs delay initiation and erode adherence. Traditional manufacturer‑sponsored copay programs, built on static rules and linear adjudication, struggle to keep pace with...
Novel Psychedelic Compound 25C-NBF Shows Rapid Antidepressant Effects without Addictive Traits
Researchers reported that the synthetic psychedelic 25C‑NBF rapidly induces dendritic growth and reverses depressive behaviors in male rodents after a single dose. The compound binds tightly to the serotonin 5‑HT2A receptor while showing minimal activity at 5‑HT2B, reducing heart‑valve risk....
Integra Reappoints Stuart Essig as CEO
Integra LifeSciences announced the reappointment of former chief executive Stuart Essig, ending the brief tenure of Mojdeh Poul. Essig returns after a 14‑year gap and will be supported by newly created chief commercial officer Michael McBreen. The leadership team says...
Want to Show Your Nurses Appreciation? Fix Your Hospital Communications
Hospitals will celebrate nurses during National Nurses Week, yet chronic communication breakdowns threaten morale and patient safety. A recent survey shows one in nine nurses learn policy changes after they’re already in effect, and more than 80% link missed messages...